India emerges as new drug trial hot spot

India emerges as new drug trial hot spot
Biotech entrepreneurs see Indian clinical trials � which can cut costs by 60 percent � as the difference between success and slow death.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!